Rchr
J-GLOBAL ID:202001003647320401   Update date: Jul. 12, 2024

Jimbo Haruki

Jimbo Haruki
Research theme for competitive and other funds  (2):
  • 2021 - 2024 頭部血管肉腫患者の血漿におけるメタボロミクス解析と腫瘍増殖機序の解明
  • 2017 - 2019 Epigenomic analysis of malignant melanoma and examination of biomarkers in immunotherapy
Papers (29):
  • Xuebing Wang, Claire Yik-Lok Chung, Ai Yoshioka, Shinya Hashimoto, Haruki Jimbo, Hideki Tanizawa, Shinya Ohta, Takeshi Fukumoto, Ken-ichi Noma. Chemo-senolytic therapeutic potential against angiosarcoma. Journal of Investigative Dermatology. 2024
  • 鷲尾 健, 岡 優実, 飯田 裕里佳, 竹内 千尋, 田中 淳仁, 山本 高正, 松浦 正徒, 神保 晴紀, 福永 淳. 血管性浮腫・特発性蕁麻疹 絞扼性イレウスで救急搬送された遺伝性血管性浮腫の1例. アレルギー. 2022. 71. 6-7. 835-835
  • Haruhiko Otsuka, Takeshi Fukumoto, Naomi Kiyota, Chihiro Takemori, Haruki Jimbo, Chikako Nishigori. Severe and delayed-onset acneiform eruptions as an adverse reaction to regorafenib. Dermatology Reports. 2022. 14. 2
  • Denitsa M. Hristova, Takeshi Fukumoto, Chihiro Takemori, Le Gao, Xia Hua, Joshua X. Wang, Ling Li, Marilda Beqiri, Andrea Watters, Adina Vultur, et al. NUMB AS A NEW THERAPEUTIC TARGET FOR MELANOMA. Journal of Investigative Dermatology. 2021
  • M. Ohata, T. Fukumoto, T. Hashimoto, C. Takemori, H. Jimbo, H. Nagai, M. Oka, C. Nishigori. Koebner phenomenon seen in a case of drug-induced granular C3 dermatosis. Clinical and Experimental Dermatology. 2021. 47. 3. 609-611
more...
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page